152 related articles for article (PubMed ID: 7902299)
21. High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.
Sievert MK; Thiriot DS; Edwards RH; Ruoho AE
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):959-66. PubMed ID: 9480916
[TBL] [Abstract][Full Text] [Related]
22. Extensive sequence divergence between the human and rat brain vesicular monoamine transporter: possible molecular basis for species differences in the susceptibility to MPP+.
Lesch KP; Gross J; Wolozin BL; Murphy DL; Riederer P
J Neural Transm Gen Sect; 1993; 93(1):75-82. PubMed ID: 8373557
[TBL] [Abstract][Full Text] [Related]
23. Direct sequencing of the reserpine-sensitive vesicular monamine transporter complementary DNA in unipolar depression and manic depressive illness.
Lesch KP; Gross J; Wolozin BL; Franzek E; Bengel D; Riederer P; Murphy DL
Psychiatr Genet; 1994; 4(3):153-60. PubMed ID: 7719701
[TBL] [Abstract][Full Text] [Related]
24. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
Schütz B; Schäfer MK; Eiden LE; Weihe E
Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
[TBL] [Abstract][Full Text] [Related]
25. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
Nirenberg MJ; Liu Y; Peter D; Edwards RH; Pickel VM
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8773-7. PubMed ID: 7568015
[TBL] [Abstract][Full Text] [Related]
26. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system.
Hansson SR; Hoffman BJ; Mezey E
Brain Res Dev Brain Res; 1998 Sep; 110(1):135-58. PubMed ID: 9733951
[TBL] [Abstract][Full Text] [Related]
27. Molecular and biochemical studies of rat vesicular monoamine transporter.
Schuldiner S; Steiner-Mordoch S; Yelin R
Adv Pharmacol; 1998; 42():223-7. PubMed ID: 9327884
[No Abstract] [Full Text] [Related]
28. A molecular glimpse of vesicular monoamine transporters.
Schuldiner S
J Neurochem; 1994 Jun; 62(6):2067-78. PubMed ID: 7910628
[No Abstract] [Full Text] [Related]
29. Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile.
Gonzalez AM; Walther D; Pazos A; Uhl GR
Brain Res Mol Brain Res; 1994 Mar; 22(1-4):219-26. PubMed ID: 7912402
[TBL] [Abstract][Full Text] [Related]
30. Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells.
Prasad PD; Hoffmans BJ; Moe AJ; Smith CH; Leibach FH; Ganapathy V
Placenta; 1996 May; 17(4):201-7. PubMed ID: 8761963
[TBL] [Abstract][Full Text] [Related]
31. Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium.
Stern-Bach Y; Keen JN; Bejerano M; Steiner-Mordoch S; Wallach M; Findlay JB; Schuldiner S
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9730-3. PubMed ID: 1357668
[TBL] [Abstract][Full Text] [Related]
32. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors.
Peter D; Jimenez J; Liu Y; Kim J; Edwards RH
J Biol Chem; 1994 Mar; 269(10):7231-7. PubMed ID: 8125935
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: stimulus-biosynthesis coupling.
Desnos C; Laran MP; Scherman D
J Neurochem; 1992 Dec; 59(6):2105-12. PubMed ID: 1279122
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123.
Watson F; Deavall DG; Macro JA; Kiernan R; Dimaline R
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):193-9. PubMed ID: 9882615
[TBL] [Abstract][Full Text] [Related]
35. Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion.
Mahata M; Mahata SK; Parmer RJ; O'Connor DT
Hypertension; 1996 Sep; 28(3):414-20. PubMed ID: 8794826
[TBL] [Abstract][Full Text] [Related]
36. Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2.
Gerhard M; Neumayer N; Presecan-Siedel E; Zanner R; Lengyel E; Cramer T; Höcker M; Prinz C
Endocrinology; 2001 Aug; 142(8):3663-72. PubMed ID: 11459816
[TBL] [Abstract][Full Text] [Related]
37. In vivo imaging of the brain vesicular monoamine transporter.
Vander Borght TM; Kilbourn MR; Koeppe RA; DaSilva JN; Carey JE; Kuhl DE; Frey KA
J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116
[TBL] [Abstract][Full Text] [Related]
38. Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
Hussain I; Bate GW; Henry J; Djali P; Dimaline R; Dockray GJ; Varro A
J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):495-505. PubMed ID: 10332097
[TBL] [Abstract][Full Text] [Related]
39. A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin, and octopamine.
Greer CL; Grygoruk A; Patton DE; Ley B; Romero-Calderon R; Chang HY; Houshyar R; Bainton RJ; Diantonio A; Krantz DE
J Neurobiol; 2005 Sep; 64(3):239-58. PubMed ID: 15849736
[TBL] [Abstract][Full Text] [Related]
40. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat.
Hansson SR; Mezey E; Hoffman BJ
Brain Res Dev Brain Res; 1998 Sep; 110(1):159-74. PubMed ID: 9733958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
